- Home
- AVIR vs NUW Comparison
AVIR vs NUW Comparison
Compare AVIR & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVIR | NUW |
|---|---|---|
| Founded | 2012 | N/A |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.0M | 259.6M |
| IPO Year | 2020 | 2008 |
Fundamental Metrics
Financial Performance| Metric | AVIR | NUW |
|---|---|---|
| Price | $4.74 | $14.31 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 580.2K | 34.2K |
| Earning Date | 04-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.46 | $13.04 |
| 52 Week High | $4.70 | $14.62 |
Technical Indicators
Market Signals| Indicator | AVIR | NUW |
|---|---|---|
| Relative Strength Index (RSI) | 71.86 | 40.56 |
| Support Level | $4.04 | $14.41 |
| Resistance Level | $4.50 | $14.62 |
| Average True Range (ATR) | 0.24 | 0.11 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 93.23 | 0.00 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About NUW Nuveen AMT-Free Municipal Value Fund
Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. The Fund's primary investment objective is to provide current income exempt from regular federal income tax. The Fund's secondary investment objective is to enhance portfolio value and total return.